Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 6/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17351201 | 0.85 | BBOX1 (0.34) | BBOX1 | |
| SCHEMBL4450608 | 0.82 | CA2 (0.35) | — | |
| SCHEMBL7053425 | 0.81 | CA2 (0.37) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL2940736 | 0.80 | BBOX1 (0.37) | KCNH2ACHEBBOX1 | |
| Trifluoromethanesulfonic Acid SCHEMBL3225327 | 0.78 | GPR3 (0.36) | KCNH2ACHEBBOX1 | |
| Trifluoromethanesulfonic Acid SCHEMBL28569605 | 0.78 | BBOX1 (0.45) | KCNH2ACHEBBOX1 | |
| SCHEMBL20972162 | 0.77 | POLB (0.33) | BBOX1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1293248 | 0.76 | GPR3 (0.39) | KCNH2ACHE | |
| Tetrylammonium SCHEMBL159930 | 0.75 | TSHR (0.42) | KCNH2ACHEBBOX1 | |
| Trifluoromethanesulfonic Acid SCHEMBL216802 | 0.74 | GPR3 (0.38) | KCNH2ACHEBBOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040222401-A1 | Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors | XU KANG (US) | 2004-11-11 | — | — | US | claimed |
| US-20040222401-A1 | Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors | XU KANG (US) | 2004-11-11 | — | — | US | disclosed |
| US-6743947-B1 | HAVING ASYMMETRIC SUBSTITUTION ON CATION; ALTERING MELTING POINT AND SOLUBILITY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2004-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040222401-A1 | Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors | VDAC2, VDAC1, HCN2 | KCNH2 86/4885ACHE 679/4885BBOX1 1644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.